Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response.

EQ-5D: a measure of health status from the EuroQol Group. Ann Med (2001) 18.69

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res (2011) 9.24

Etiology and management of fecal incontinence. Dis Colon Rectum (1993) 7.68

Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum (2000) 5.07

Prospective comparison of faecal incontinence grading systems. Gut (1999) 3.48

Community-based prevalence of anal incontinence. JAMA (1995) 3.03

Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology (2003) 2.92

Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology (2009) 2.52

Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut (2002) 2.41

Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet (2011) 2.33

Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol (1996) 2.25

The clinical implications of isolated alpha(1) adrenergic stimulation. Anesth Analg (2011) 1.98

Efficacy of sacral nerve stimulation for fecal incontinence: results of a multicenter double-blind crossover study. Ann Surg (2005) 1.84

Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain (2005) 1.68

Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg (2000) 1.61

What is the impact of fecal incontinence on quality of life? Dis Colon Rectum (2001) 1.50

Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev (2012) 1.45

Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med (1999) 1.32

Accidental bowel leakage in the mature women's health study: prevalence and predictors. Int J Clin Pract (2012) 1.14

Impact of fecal incontinence on quality of life. World J Gastroenterol (2009) 1.12

Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes. World J Gastroenterol (2013) 1.11

Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol (2012) 1.08

Validation of the French version of the Fecal Incontinence Quality-of-Life (FIQL) scale. Gastroenterol Clin Biol (2004) 1.05

Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev (2013) 1.04

Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut (2001) 1.02

Anal physiology testing in fecal incontinence: is it of any value? Int J Colorectal Dis (2009) 1.01

Elastomer implants in faecal incontinence: a blind, randomized placebo-controlled study. Aliment Pharmacol Ther (2007) 1.00

Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 0.96

Topical phenylephrine increases anal sphincter resting pressure. Br J Surg (1999) 0.95

Fecal incontinence: prevalence, severity, and quality of life data from an outpatient gastroenterology practice. Gastroenterol Res Pract (2011) 0.94

Adaptation to Spanish language and validation of the fecal incontinence quality of life scale. Dis Colon Rectum (2006) 0.94

Cognitive and emotional factors in placebo analgesia. J Psychosom Res (2006) 0.91

Reasons for non-disclosure of faecal incontinence: a comparison between two survey methods. Tech Coloproctol (2007) 0.88

Outcome and management of patients in whom sacral nerve stimulation for fecal incontinence failed. Dis Colon Rectum (2011) 0.88

Peripheral neuromodulation via posterior tibial nerve stimulation - a potential treatment for faecal incontinence? Ann R Coll Surg Engl (2010) 0.86

Restraint and internal responsiveness: effects of placebo manipulations of hunger state on eating. J Abnorm Psychol (1989) 0.85

Migraine treatment and placebo effect. Expert Rev Neurother (2010) 0.84

Current and emerging treatment options for fecal incontinence. J Clin Gastroenterol (2014) 0.83

The pharmacology of the internal anal sphincter and new treatments of ano-rectal disorders. Aliment Pharmacol Ther (2001) 0.83

Fecal incontinence. Clin Colon Rectal Surg (2007) 0.82

Reduction of motion sickness with an enhanced placebo instruction: an experimental study with healthy participants. Psychosom Med (2013) 0.82

Overlapping anal sphincter repair and anterior levatorplasty: effect of patient's age and duration of follow-up. Int J Colorectal Dis (2006) 0.81

Novel treatment options for fecal incontinence. Clin Colon Rectal Surg (2014) 0.80

L-Erythro-methoxamine is more potent than phenylephrine in effecting contraction of internal anal sphincter in vitro. Br J Surg (2003) 0.80

Sphincteroplasty for fecal incontinence in the era of sacral nerve modulation. World J Gastroenterol (2010) 0.80

The SECCA procedure for faecal incontinence: a review. Colorectal Dis (2014) 0.78

Intra-anal application of L-erythro methoxamine gel increases anal resting pressure in patients with incontinence. Br J Surg (2007) 0.78

Libertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence. Colorectal Dis (2014) 0.78

Intra-anal and rectal application of L-erythro methoxamine gel increases anal resting pressure in healthy volunteers. Br J Surg (2005) 0.78

Quality of life after sphincteroplasty. Acta Chir Iugosl (2004) 0.77

A randomised, controlled, crossover study to investigate the safety and response of 1R,2S-methoxamine hydrochloride (NRL001) on anal function in healthy volunteers. Colorectal Dis (2014) 0.77

A randomised, controlled, crossover study to investigate the pharmacodynamics, pharmacokinetics and safety of 1R,2S-methoxamine hydrochloride (NRL001) in healthy elderly subjects. Colorectal Dis (2014) 0.77

Meta-analysis for cardiovascular effects of NRL001 after rectal application in healthy volunteers. Colorectal Dis (2014) 0.77

A double-blind, placebo-controlled, randomised, parallel-group, dose-escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 suppositories for 14 days. Colorectal Dis (2014) 0.76

Randomised clinical trial: study of escalating doses of NRL001 given in rectal suppositories of different weights. Colorectal Dis (2014) 0.76

Surgical repair of fecal incontinence. Correlation of sonographic anal sphincter integrity with subjective cure. J Reprod Med (1998) 0.76

Results of surgical treatment for faecal incontinence. Br J Surg (2000) 0.76